Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Bedside monitoring of antiplatelet therapy for coronary stenting.

Neubauer H, Meves SH.

N Engl J Med. 2013 Feb 28;368(9):870-1. doi: 10.1056/NEJMc1300053#SA1. No abstract available.

PMID:
23445101
2.

Bedside monitoring of antiplatelet therapy for coronary stenting.

De Caterina R, Marchioli R, Andreotti F.

N Engl J Med. 2013 Feb 28;368(9):871. doi: 10.1056/NEJMc1300053#SA2. No abstract available.

PMID:
23445102
3.

Bedside monitoring of antiplatelet therapy for coronary stenting.

Montalescot G, Vicaut E, Collet JP.

N Engl J Med. 2013 Feb 28;368(9):871-2. doi: 10.1056/NEJMc1300053. No abstract available.

4.

Bedside monitoring to adjust antiplatelet therapy for coronary stenting.

Collet JP, Cuisset T, Rangé G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrié D, Boueri Z, Belle L, Van Belle E, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthélémy O, Beygui F, Silvain J, Vicaut E, Montalescot G; ARCTIC Investigators.

N Engl J Med. 2012 Nov 29;367(22):2100-9. doi: 10.1056/NEJMoa1209979. Epub 2012 Nov 4.

5.

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K.

N Engl J Med. 1996 Apr 25;334(17):1084-9.

6.

Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.

Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R.

Thromb Haemost. 2010 Aug;104(2):287-92. doi: 10.1160/TH09-12-0832. Epub 2010 May 10.

PMID:
20458439
7.

Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.

Kastrati A, Schühlen H, Hausleiter J, Walter H, Zitzmann-Roth E, Hadamitzky M, Elezi S, Ulm K, Dirschinger J, Neumann FJ, Schömig A.

Circulation. 1997 Jul 15;96(2):462-7.

PMID:
9244213
8.

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.

Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H, Vrolix M, Missault L, Chierchia S, Casaccia M, Niccoli L, Oto A, White C, Webb-Peploe M, Van Belle E, McFadden EP.

Circulation. 1998 Oct 20;98(16):1597-603.

9.
10.

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.

van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM.

Platelets. 2008 Nov;19(7):479-88. doi: 10.1080/09537100802317918. Review.

PMID:
18979359
11.

Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.

Moerenhout CM, Claeys MJ, Haine S, Miljoen H, Bosmans JM, Vertessen F, Kluppels K, Van der Planken M, Vrints CJ.

Am Heart J. 2010 Mar;159(3):434-8. doi: 10.1016/j.ahj.2009.12.020.

PMID:
20211306
12.

Ticlopidine and aspirin therapy following implantation of coronary artery stents.

Hobson AG, Sowinski KM.

Ann Pharmacother. 1997 Jun;31(6):770-2. Review.

PMID:
9184720
13.

Ticlopidine after stenting: "Render unto Caesar that which belongs to Caesar".

Corcos T, Favereau X, Guérin Y.

Cathet Cardiovasc Diagn. 1998 May;44(1):97-8. No abstract available.

PMID:
9600534
14.

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.

Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N.

Thromb Haemost. 2010 Jan;103(1):151-9. doi: 10.1160/TH09-05-0284. Epub 2009 Oct 26.

PMID:
20062919
15.
16.

Intracoronary stenting without intravascular ultrasound guidance followed by antiplatelet therapy with aspirin alone in selected patients.

Roy PR, Lowe HC, Walker BW, Baron DW, Gavaghan TP, Morgan JJ.

Am J Cardiol. 1996 May 15;77(12):1105-7.

PMID:
8644666
17.

Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.

Jauhar R, Bergman G, Savino S, Deutsch E, Shaknovich A, Parikh M, Sanborn TA.

Am J Cardiol. 1999 Sep 15;84(6):726-8, A8.

PMID:
10498144
18.

Antiplatelet and anticoagulant therapy after coronary-artery stenting.

Schöneberger AA, Schmidt K.

N Engl J Med. 1996 Oct 10;335(15):1160; author reply 1161. No abstract available.

19.

Antiplatelet and anticoagulant therapy after coronary-artery stenting.

Cequier A, Sabaté M, Esplugas E.

N Engl J Med. 1996 Oct 10;335(15):1160-1. No abstract available.

PMID:
8848026
20.

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.

Gawaz M, Seyfarth M, Müller I, Rüdiger S, Pogatsa-Murray G, Wolf B, Schömig A.

Am J Cardiol. 2001 Feb 1;87(3):332-6, A9.

PMID:
11165971

Supplemental Content

Support Center